SNCA and Parkinson disease: We have further tested these mice for vulnerability to αSyn toxicity by using an AAV-A53T-SNCA overexpression mouse model that recapitulates key PD features, including motor deficits, dopamine depletion in the striatum and synucleinopathy, chronically at 28 weeks post-injection of the vector.